Berlin - Delayed Quote EUR

Iovance Biotherapeutics Inc (2LB.BE)

Compare
8.20 +0.43 (+5.56%)
As of 8:01 AM GMT+1. Market Open.
Loading Chart for 2LB.BE
DELL
  • Previous Close 7.77
  • Open 8.20
  • Bid 8.20 x --
  • Ask 8.32 x --
  • Day's Range 8.20 - 8.20
  • 52 Week Range 5.00 - 16.50
  • Volume 0
  • Avg. Volume 0
  • Market Cap (intraday) --
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) --
  • EPS (TTM) --
  • Earnings Date Nov 7, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Recent News: 2LB.BE

View More

Performance Overview: 2LB.BE

Trailing total returns as of 11/25/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

2LB.BE
4.67%
S&P 500
25.15%

1-Year Return

2LB.BE
60.05%
S&P 500
30.93%

3-Year Return

2LB.BE
50.62%
S&P 500
26.97%

5-Year Return

2LB.BE
56.82%
S&P 500
91.92%

Compare To: 2LB.BE

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 2LB.BE

View More

Valuation Measures

Annual
As of 11/22/2024
  • Market Cap

    2.49B

  • Enterprise Value

    2.19B

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    24.86

  • Price/Book (mrq)

    3.21

  • Enterprise Value/Revenue

    25.17

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    --

  • Return on Assets (ttm)

    --

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    --

  • Net Income Avi to Common (ttm)

    --

  • Diluted EPS (ttm)

    --

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    --

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    --

Research Analysis: 2LB.BE

View More

Company Insights: 2LB.BE

Research Reports: 2LB.BE

View More